University of Manitoba Initiates ‘Siteless’ Trial Investigating Efficacy of Hydroxychloroquine for COVID-19

University of Manitoba Initiates ‘Siteless’ Trial Investigating Efficacy of Hydroxychloroquine for COVID-19

The University of Manitoba in Canada is the participating in its first clinical trial to test whether the malaria drug called hydroxychloroquine can prevent people from contracting COVID-19. Led by the Rady Faculty of Health Sciences, it commenced recently and the...

Pin It on Pinterest